logo-loader
viewPropanc Biopharma, Inc.

Propanc Biopharma taps longtime advisor as chief financial officer

Carlo Campiciano joins the biopharma as it enters important new phases of growth

calculator and spreadsheets
Campiciano previously served as CFO at a startup, had a private accounting business and lectured at Swinburne University

Propanc Biopharma Inc (OTCMKTS:PPCB) has announced the hiring of Carlo Campiciano as chief financial officer effective July 1.

Campiciano has been an external advisor to Propanc for more than 10 years. Previously, he served as CFO at a startup, had a private accounting business and lectured at Swinburne University in Melbourne, Australia. He’s also a member of the Australian Institute of Public Accountants and is GAAP certified in the US.

READ: Propanc CEO looks to harness power of pancreatic enzymes in cancer fight

The Melbourne-based company is developing new cancer treatments for patients suffering from recurring and metastatic cancer by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from pancreatic, ovarian and colorectal cancers.

Campiciano joins the biopharma as it enters important new phases of growth, with an eye toward uplisting to a US stock exchange.

“As we progress towards submitting a clinical trial application for our First-In-Human study for PRP, we are turning our attention to the next phase in our development as a clinical-stage company, and are very pleased to welcome Carlo’s proven experience and capabilities,” said Propanc CEO James Nathanielsz in a statement.

“This is an exciting time to join the talented Propanc management team and extends my involvement with Propanc from that of an external advisor for more than 10 years, to having a real influence in shaping the future of the business as Chief Financial Officer,” said Campiciano.  “I believe my skills and experience with high growth businesses will be valuable in contributing to the next phase of the company’s growth and evolution.”

Contact Paul Curcio at [email protected]

Follow him on Twitter @GoCurcioGo

Quick facts: Propanc Biopharma, Inc.

Price: 0.0016 USD

OTCMKTS:PPCB
Market: OTCQB
Market Cap: $75.34 k
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Hire Technologies VP of Finance provides insights into acquisition strategy...

Hire Technologies (CVE: HIRE) Vice President of Finance Dan Teguh joined Steve Darling from Proactive to share some insight into the acquisition strategy for the company and the calculations behind it. Teguh shares his formula and also what they look for in the management teams.

11 hours, 41 minutes ago

2 min read